← Leaderboards
Raffit Hassan
University Of Oklahoma Hlth Sciences Ctr
$23,585
Attributed
$23,585
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$23,585 · 1
By mechanism
K23$23,585 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Mesothelioma”
- Michele Carbone · University Of Hawaii At Manoa$10,761,809
- Joseph Robert Testa · Fox Chase Cancer Center$9,590,137
- Steven Mark Albelda · University Of Pennsylvania$8,632,827
- Prasad S. Adusumilli · Sloan-Kettering Inst Can Research$7,347,340
- Raphael Bueno · Brigham And Women'S Hospital$5,927,551
- Harvey Ira Pass · New York University School Of Medicine$5,330,170
Research focus
Malignant MesotheliomaClinical TrialsMesothelinMalignant NeoplasmsConduct Clinical TrialsImmunotoxinsMonoclonal AntibodiesImmunotherapyMalignant Neoplasm Of ThoraxDrug TargetingPreclinical StudyImmunotherapeutic AgentAntibodiesPleuraPeritoneumMalignant Neoplasm Of ThymusTumorPancreatic AdenocarcinomaMesothelial CellProgramsMesotheliomaNon-Small-Cell Lung CarcinomaSafetyTumor Antigens
Grant awards (34)
Adoptive cell therapy for malignant mesothelioma and other mesothelin expressing$3,067,127
ZIA · FY2025 · CA · contact PI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core$968,567
ZID · FY2025 · CA · contact PI
Adoptive cell therapy for malignant mesothelioma and other mesothelin expressing$3,790,575
ZIA · FY2024 · CA · contact PI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core$1,197,024
ZID · FY2024 · CA · contact PI
Immunotherapy for Malignant Mesothelioma and Lung Cancer$2,148,642
ZIA · FY2023 · CA · contact PI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core$1,555,914
ZID · FY2023 · CA · contact PI
Immunotherapy for Malignant Mesothelioma and Lung Cancer$2,018,756
ZIA · FY2022 · CA · contact PI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core$1,461,857
ZID · FY2022 · CA · contact PI
Immunotherapy for Malignant Mesothelioma and Lung Cancer$1,907,385
ZIA · FY2021 · CA · contact PI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core$1,381,210
ZID · FY2021 · CA · contact PI
Immunotherapy for Malignant Mesothelioma and Lung Cancer$1,865,336
ZIA · FY2020 · CA · contact PI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core$1,350,761
ZID · FY2020 · CA · contact PI
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies$1,506,569
ZIA · FY2019 · CA · contact PI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core$1,336,014
ZID · FY2019 · CA · contact PI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core$1,826,226
ZID · FY2018 · CA · contact PI
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies$820,478
ZIA · FY2018 · CA · contact PI
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core$1,890,317
ZID · FY2017 · CA · contact PI
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies$849,274
ZIA · FY2017 · CA · contact PI
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core$2,214,926
ZID · FY2016 · CA · contact PI
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies$995,112
ZIA · FY2016 · CA · contact PI
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core$1,755,551
ZID · FY2015 · CA · contact PI
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies$1,075,984
ZIA · FY2015 · CA · contact PI
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies$1,261,829
ZIA · FY2014 · CA · contact PI
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core$741,074
ZID · FY2014 · CA · contact PI
Immunotherapy for Malignant Mesothelioma$947,902
ZIA · FY2013 · CA · contact PI
Immunotherapy for Malignant Mesothelioma$914,751
ZIA · FY2012 · CA · contact PI
Immunotherapy for Malignant Mesothelioma$798,901
ZIA · FY2011 · CA · contact PI
Immunotherapy for Malignant Mesothelioma$809,969
ZIA · FY2010 · CA · contact PI
Immunotherapy for Malignant Mesothelioma$725,065
ZIA · FY2009 · CA · contact PI
Immunotherapy for Malignant Mesothelioma$595,766
Z01 · FY2008 · CA · contact PI
Immunotherapy for Malignant Mesothelioma$661,211
Z01 · FY2007 · CA · contact PI
Targeted Therapy of Mesothelioma and Development of Bloo$0
Z01 · FY2006 · BC · contact PI
Targeted therapy of mesothelin expressing cancers using$0
Z01 · FY2005 · BC
Clinical evaluation of an anti-mesothelin immunotoxin$23,585
K23 · FY2002 · CA